ARS Pharmaceuticals, Inc. (SPRY)

SPRY is near 5.62 and presents a weak-to-bearish technical picture with price below most moving averages and long-term averages substantially higher, reflecting persistent downside pressure. Momentum indicators are muted to slightly negative, MACD is marginally below zero, and ADX around 24.66 shows limited trend conviction rather than a decisive uptrend. On-balance volume is deeply negative, consistent with distribution, and ATR is elevated at roughly 6.76%, implying higher intraday swings amid the down bias. Technical takeaway: Strong Sell.